NEWS
View news from our Featured Companies.
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024
PETACH TIKVA, Israel, July 31, 2024 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its second quarter 2024 financial results and operational...
Kiora Pharmaceuticals Receives European Orphan Medicinal Product Designation for KIO-301 for the Treatment of Inherited Retinal Dystrophies
Encinitas, California--(July 30, 2024) - Kiora Pharmaceuticals (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it has received Orphan Medicinal Product Designation from the European Medicines Agency (EMA) for the treatment of a group of inherited retinal...
Mogo to Announce Q2 2024 Financial Results August 8, 2024
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital wealth and payments business, today announced it will hold a conference call and webcast to discuss its Q2 2024 financial results on Thursday, August 8, 2024 at 1:00...
LiqTech and Danbee Marine Co. Ltd. Enter Agreement for Marine Scrubber Water Treatment Solutions for the South Korean Market
BALLERUP, Denmark, July 25, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and systems for marine, and Danbee Marine, a South Korean-based maritime representative...
IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
Winter Springs, Fla., July 25, 2024 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market opens on Thursday, August 1, 2024. Iradimed management will host a conference call the...
LiqTech International to Discuss Second Quarter 2024 Results on Wednesday, August 14, 2024
Management to Host Conference Call on Wednesday, August 14, 2024, at 9:00 a.m. ET BALLERUP, Denmark, July 24, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products and...
ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it will hold a conference call on Wednesday, August 7, 2024 at 4:30 p.m. ET to discuss its financial...
SenesTech Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on July 25, 2024 PHOENIX, July 23, 2024 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced...
ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs)
Results from the at-home test kit are available to HCPs and their patients through 1health LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, launches the Niagen+ NAD+...
Mogo Becomes Exclusive Canadian Partner of Top-Ranked Wall Street Investment Strategist Tom Lee & Fundstrat to Bring Their Equity Market Research to Mogo’s Digital Wealth Customers
Includes exclusive access to equity research, webinars, interviews and appearances with top Wall Street strategist Tom Lee, Founder of Fundstrat and contributing editor at CNBC Ties to Mogo's objective to give its wealth customers an investing edge to outperform and...
ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announces the appointment of Carlos Lopez as Senior Vice President, General Counsel. Mr. Lopez will oversee the...
LiqTech Delivers Produced Water Treatment Pilot Unit to NESR for Middle East Operations
BALLERUP, Denmark and HOUSTON, July 18, 2024 -- LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration technology company that manufactures and markets highly specialized filtration products and systems, today announced it has successfully delivered a...
Cadrenal Therapeutics to Present at the Emerging Growth Conference on July 18, 2024
PONTE VEDRA, Fla., July 17, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, new-generation Vitamin K Antagonist (VKA) oral and reversible anticoagulant (blood thinner) designed to prevent heart...
Dror Ortho-Design, Inc. Launches New ZSMILE Product Brand
JERUSALEM, July 17, 2024 -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), an AI-based orthodontic platform company that has developed a proprietary solution to correct people's smiles by straightening teeth using pulsating air delivered by a...
ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August
U.S. FDA-registered 503B outsourcing facility, Wells Pharma of Houston, will compound and distribute Niagen (nicotinamide riboside chloride) IV and injections to Cenegenics, Clean Market/NutriDrip, Drip Hydration, EXTEN IV, Kensho Wellbeing, The NAD MD, Next Health,...
Jewett-Cameron Announces 3rd Quarter Financial Results
NORTH PLAINS, Ore., July 15, 2024 -- Jewett-Cameron Trading Company Ltd. (NASDAQ: JCTCF) today reported financial results for the third quarter and nine-month periods of fiscal 2024 ended May 31, 2024. Sales for the third quarter of fiscal 2024 totaled approximately...
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform
Pre-clinical study to explore use of MODD1 pump as a delivery system for FDA-approved, short acting peptides, as a personalized alternative for people who discontinue long-acting GLP-1 formulations SAN DIEGO, CA / July 15, 2024 / Modular Medical, Inc. (NASDAQ:MODD)...
Greenfire Resources Announces Redemption of US$61 Million of the Company’s US$300 Million Senior Secured Notes Due 2028
Calgary, Alberta--(July 10, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development of thermal energy resources from the Athabasca region of Alberta, Canada, is...
Kiora Pharmaceuticals to Participate in Jones Healthcare Seaside Summit 2024; Kiora Invites Investors to Submit Questions Following the Conference Presentation
Encinitas, California--(July 10, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (KPRX) ("Kiora" or the "Company"), today announced that Eric Daniels, M.D., Chief Development Officer, will present at the Jones Trading Healthcare Seaside Summit on Monday, July 15 at...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024
PORTLAND, Maine, July 09, 2024 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension
- Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD) -Similar patents have...
Precision Optics Appoints Clay Schwabe as VP of Sales and Marketing
GARDNER, Mass., July 08, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced the appointment of Clay Schwabe, as the Company's Vice...
ChromaDex to Join Russell 2000® Index
ChromaDex continues to drive innovation and growth with its proprietary Tru Niagen® supplement, backed by strong financial performance and a robust intellectual property portfolio LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide...
Biotech Executive Lisa Walters-Hoffert Joins Kiora Pharmaceuticals’ Board of Directors
Ken Gayron to Step Down as a Member of the Company's BoardEncinitas, California--(July 1, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced that it has appointed Lisa Walters-Hoffert as an independent member to the Company's...
ARIANNE PHOSPHATE ANNOUNCES RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC , June 28, 2024 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTC: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul project...